VVOS News and Press, Vivos Therapeutics Inc. From 04/01/24

2024-04-01 10:00:18 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 93.4% to $0.117 on volume of 124,152,860 shares Jaguar Health Inc. (JAGX) fell 9.0% to $0.0818 on volume of 39,020,683 shares CXApp Inc. (CXAI) rose 82.9% to $4.48 on volume of 34,784,405 shares N...

2024-03-28 23:10:02 ET Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Conference Call March 28, 2024 05:00 PM ET Company Participants Julie Gannon - Investor Relations Officer Kirk Huntsman - Chairman & Chief Executive Officer Brad Amman - Chief Financial O...

2024-03-28 17:05:52 ET More on Vivos Therapeutics Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therapeutics Read the full article on Seeking Alpha For further...

Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses Declined 27% Due to Success of Cost Cutting Initiatives Management to Host Conf...

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...

LITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatment...

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”))....

2024-02-15 08:17:12 ET More on Vivos Therapeutics Vivos stock rallies after FDA clears oral device treatment for severe sleep apnea Seeking Alpha’s Quant Rating on Vivos Therapeutics Read the full article on Seeking Alpha For further details see: V...

LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for ...